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Abstract
OBJECTIVES—To determine whether older adults with type 2 diabetes mellitus and cognitive 
dysfunction have poorer metabolic control of glycosylated hemoglobin, systolic blood pressure, 
and low-density lipoprotein cholesterol than those without cognitive dysfunction.
DESIGN—Prospective cohort study.
SETTING—A minority cohort in New York City previously recruited for a trial of telemedicine.
PARTICIPANTS—Persons aged 73.0 ± 3.0 (N = 613; 69.5% female; 82.5% Hispanic, 15.5% 
non-Hispanic black).
MEASUREMENTS—Participants were classified with executive or memory dysfunction based 
on standardized score cutoffs (<16th percentile) for the Color Trails Test and Selective Reminding 
Test. Linear mixed models were used to compare repeated measures of the metabolic measures 
and evaluate the rates of change in individuals with and without dysfunction.
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RESULTS—Of the 613 participants, 331 (54%) had executive dysfunction, 202 (33%) had 
memory dysfunction, and 96 (16%) had both. Over a median of 2 years, participants with 
executive or memory dysfunction did not exhibit significantly poorer metabolic control than those 
without executive function or memory type cognitive dysfunction.
CONCLUSION—Cognitive dysfunction in the mild range did not seem to affect diabetes 
mellitus control parameters in this multiethnic cohort of older adults with diabetes mellitus, 
although it cannot be excluded that cognitive impairment was overcome through assistance from 
formal or informal caregivers. It is possible that more-severe cognitive dysfunction could affect 
control.
Keywords
cognition; diabetes mellitus; control; elderly
Appropriate self-management of diabetes mellitus is important for the prevention of diabetes 
mellitus– related complications and other adverse outcomes.1 Poor self-management can 
lead to a greater incidence of diabetic complications, such as micro- and macrovascular 
disease, and death.2 Individuals with diabetes mellitus have been shown to have a risk of 
cognitive decline that is 1.2–1.5 times as great as that of individuals without diabetes 
mellitus.3 Executive function and memory declines are the most frequently reported 
cognitive deficits in the setting of diabetes mellitus.4 Executive or memory dysfunctions 
may cause inappropriate self-management behaviors, including mishandling of or poor 
adherence to medication regimens, incorrect administration of insulin, and nutritional 
imbalance in daily meals, which can result in poor metabolic and physical outcomes. There 
is a dearth of studies addressing diabetes mellitus in older adults.5 The long-term effect of 
diabetes mellitus–related cognitive decline on disease self-management in older adults, 
specifically the effect on measures of metabolic control, is understudied. This question is 
particularly important in Hispanics and non-Hispanic blacks, who have a higher prevalence 
of concomitant diabetes mellitus and cognitive impairment.6
Few studies have quantified the association between cognitive dysfunction and poor self-
management in individuals with diabetes mellitus.7–15 Findings relating cognitive 
dysfunction to metabolic control are conflicting. One study found greater executive 
dysfunction to have no effect on glycemic control,8 whereas two others found global 
cognitive dysfunction10 and executive dysfunction15 to be associated with higher 
glycosylated hemoglobin (HbA1c) levels. Methodological concerns, including, small sample 
sizes, limited clinical measures of diabetes mellitus control, and the cross-sectional nature of 
these studies limit their interpretation.
The risk of cognitive dysfunction in the setting of diabetes mellitus is high.6 Thus, it was 
hypothesized that cognitive dysfunction would affect diabetes mellitus control in elderly 
persons with diabetes mellitus. This hypothesis was tested by studying the longitudinal 
relationship between cognitive dysfunction and changes in parameters of diabetes mellitus 
control, HbA1c, systolic blood pressure (SBP), and low-density lipoprotein cholesterol 
(LDL-C) in a sample of predominantly minority elderly adults with diabetes mellitus 
residing in northern Manhattan.
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Study Population and Design
Participants in these analyses were a subsample recruited for a cognition ancillary study 
from the New York City sample of the Informatics for Diabetes Education and Telemedicine 
(IDEATel) Project.16 IDEATel was designed to assess the feasibility and effectiveness of 
telemedicine for disease management in a sample of minority older adults with type 2 
diabetes mellitus living in New York State.16 Their primary care providers recruited 
participants from New York City (Columbia University) and upstate New York (State 
University of New York Upstate Medical University at Syracuse). They were randomized 
between 2000 and 2002 to the intervention (a home-based interactive telemedicine unit used 
for televisits with a nurse educator, transmission of self-measured glucose and blood 
pressure data electronically, and web access in addition to usual care) or usual care alone. 
The primary endpoints were changes in HbA1c, blood pressure, and LDL-C. Participants (N 
= 1,665) were individuals aged 55 and older with a physician or medication-defined 
diagnosis of diabetes mellitus who were Medicare beneficiaries and resided in a federally 
designated medically underserved area. Participants were excluded if they were moderately 
to severely cognitively impaired; had a severe visual, mobility, or motor impairment; had a 
severe comorbid condition, a communication impairment, or no electrical outlet for the 
telemedicine unit; or planned to reside in another location for longer than 3 months. Details 
regarding inclusion and exclusion, the randomization scheme, the intervention, and 
evaluation of primary endpoints are described elsewhere.16,17
An ancillary cognition study was initiated in the second phase (2004–08) of IDEATel at the 
Columbia University site. Five hundred participants who completed the first phase at this 
site (n = 775) continued on to the second phase. An additional 150 subjects were recruited to 
participate in the second phase. The only exclusion criteria for this ancillary study were 
unwillingness or inability to begin or complete the cognitive assessments. In addition to the 
global cognition measures administered in the first phase, an extended neuropsychological 
assessment with measures of memory, executive function, language, attention, and 
construction were administered in this ancillary study at 1-year intervals. Six hundred 
thirteen participants were included in this 5-year prospective analysis of the ancillary study 
data, 538 (87.7%) of whom had one follow-up visit, 437 (71.2%) two follow-up visits, 350 
(57.1%) three follow-up visits, 231 (37.7%) four follow-up visits, and 90 (14.7%) five 
follow-up visits. Written informed consent was obtained from participants. The Columbia 
University institutional review board approved all protocols for this study.
Assessment of Cognitive Dysfunction
Cognitive dysfunction was classified as executive and memory dysfunction because these 
types seem to be most relevant to the management of diabetes mellitus. Executive 
dysfunction is broadly defined as the ability to plan, initiate, and execute complex tasks18 
(e.g., planning and completing diabetes mellitus treatment), whereas memory is defined as 
the ability to recall (e.g., remembering to take diabetes mellitus medications).19 Executive 
dysfunction was assessed based on the participant’s performance on the Color Trails Test 
Part 2, a test of executive functioning and mental flexibility.20 The Color Trails Test is 
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similar in form to the Trail-Making Test Part B,21 but it removes the cultural bias associated 
with unfamiliarity with the English alphabet.22 The majority of the cohort was Hispanic, and 
this test is well suited to individuals whose first language is not English. Instead of 
connecting numbers to Arabic letters, the Color Trails Test requires participants to connect 
numbers and colors. Each number is overlaid on a colored circle, pink or yellow.22 
Participants are asked to connect the numbers 1–25 in ascending order but to alternate 
between colors (pink-1, yellow-2, pink-3, yellow-4, etc.).22 A cutoff for an abnormal score 
was defined as performance in less than the 16th percentile (roughly 1 standard deviation 
(SD) below the standardized test score mean).23,24 This cutoff was used because test 
performance 1 SD below the mean is typically used in clinical settings to categorize 
individuals as having abnormal cognitive functioning.23,24 Studies of cognition, in general, 
are increasingly studying this range of cognitive dysfunction25 as compared to the more 
frequently used classification of mild cognitive impairment (MCI), which uses 1.5 SDs as a 
cutoff for normal cognitive performance.
Memory dysfunction was assessed based on the participant’s performance on the total 
immediate memory task of the Selective Reminding Test (SRT), a 12-item list-learning 
verbal memory test.26 SRT total score was converted to a T-score based on the participant’s 
age, sex, education, and race and ethnicity. An abnormal T-score was defined as 
performance in under the 16th percentile (1 SD below the standardized test score mean) of 
SRT immediate recall T-scores in the sample.23,24 Based on this criterion, a participant with 
a T-score <28 on the SRT immediate recall task was classified with memory dysfunction.
Cognitive dysfunction was examined in terms of executive function and memory as an 
exposure in two ways: relating cognitive dysfunction at baseline to the outcomes and using 
all available follow-up data on cognitive dysfunction and classifying participants as ever or 
never having cognitive dysfunction. There was little difference in results between using the 
baseline cognitive dysfunction status definition and using the ever–never definition.
Outcomes
Changes in measures of metabolic control (HbA1c, SBP, LDL-C) were evaluated. Twelve-
hour fasting blood samples were collected to assess HbA1c and lipid levels. HbA1c was 
analyzed using boronate affinity chromatography using high-performance liquid 
chromatography (Primus CLC 385; Primus, Kansas City, MO). Lipid levels were analyzed 
using enzymatic colorimetric methods (Vitros; Johnson & Johnson, New Brunswick, NJ). 
LDL-C was calculated using the Friedwald equation.27 SBP was determined as the average 
of the last two of three readings taken 1 minute apart (Dinamap PRO 100; Critikon, Tampa, 
FL).28
Statistical Analysis
Descriptive analyses were conducted using chi-square tests for categorical variables and the 
Kruskal–Wallis test for continuous variables to test for significant differences in participant 
characteristics between individuals with and without cognitive dysfunction, executive and 
memory type separately.
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Linear mixed models29 were used to examine the longitudinal relationship between ever 
versus never presence of executive or memory dysfunction and changes in parameters of 
metabolic control (HbA1c, SBP, LDL-C). Models included random effects for intercepts 
(individuals) and clustering within primary care provider, which was the unit of recruitment 
in IDEATel.19 To estimate the association between executive or memory dysfunction and 
changes in measures of metabolic control, an interaction term between cognitive dysfunction 
status (executive or memory type) and time was included. Nonlinearity was assessed and 
goodness-of-fit statistics were used (Akaike Information Criterion and Schwarz’s Bayesian 
Information Criterion) to assess model fit. Model fit was not improved with inclusion of a 
quadratic (group by time2) or exponential term (group by e−time) for time. Demographic 
characteristics that are known to be associated with cognitive dysfunction and the metabolic 
measures (age, sex, years of education, race and ethnicity) were adjusted for. To account for 
residual effects of the IDEATel treatment, the randomization group assignment was 
included in the final model. Symptomatology of depression and cognitive dysfunction are 
similar and often mistaken for one another, so the presence or absence of depressive 
symptoms, as measured using the SHORT Comprehensive Assessment and Referral 
Evaluation Depression questionnaire,30 was included in the final model. Insulin, metformin, 
sulfonylurea, or thiazolidinedione medication use was further adjusted for in models of 
HbA1c to account for possible confounding by indication. Analyses were performed using 
Stata 13.0 (Stata Corp, College Station, TX).
RESULTS
Six hundred thirteen participants were included in this analysis (Table 1). The mean age was 
73, and 70% were women. Participants had an average of 7.5 years of education. Most 
participants were Hispanic (82.5%) or non- Hispanic black (15.5%), with fewer than 1.0% 
reporting non-Hispanic white race.
In terms of executive dysfunction, 331 of 613 participants (54%) performed in the lowest 
16th percentile of test scores for the Color Trails Test Part 2 at a minimum of one visit 
throughout follow-up (Table 1). Age, sex, education, and race and ethnicity were not 
statistically different between participants classified with and without executive dysfunction. 
There was no difference in adjusted baseline measurements or rates of change in metabolic 
measures between participants with and without executive dysfunction (Table 2).
Thirty-three percent of participants (n = 202) were classified with memory dysfunction 
(Table 1). Women were more likely to have memory dysfunction than men, and participants 
with memory dysfunction had attained, on average, one less grade of education. No 
significant adjusted baseline differences were observed between participants with diabetes 
mellitus with and without memory dysfunction (Table 3). Significant longitudinal 
differences were observed in SBP. Participants with memory dysfunction had more declines, 
as opposed to increases, in SBP across follow-up than those without (Table 3).
Whether ever having executive or memory dysfunction was related to diabetes mellitus 
control was explored; 437 (71.2%) participants demonstrated ever having any type of 
dysfunction, but this exposure was not longitudinally related to HbA1c, SBP, or LDL-C.
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Sixteen percent (n = 96) of participants had executive and memory dysfunction throughout 
follow-up. No significant baseline or longitudinal differences were observed between 
participants with comorbid executive and memory dysfunction and those without executive 
and memory dysfunction (n = 176).
DISCUSSION
Neither executive dysfunction nor memory dysfunction in the mild range were 
independently associated with diabetes mellitus control in longitudinal analyses in this 
sample of older adults with diabetes mellitus.
These results both conflict and agree with the results of prior research. A cross-sectional 
study of older African Americans with diabetes mellitus found that HbA1c values were 0.23 
units lower for each unit increase in higher executive function score.15 Another cross-
sectional study of older adults reported that global cognitive dysfunction was inversely 
correlated with HbA1c.10 In comparison, a small study of older adult men found no 
correlation between executive dysfunction and HbA1c, lipid levels, or blood pressure.8 
Differences in findings may be due to heterogeneity in study populations but may also be 
due to the cognitive measures selected. The findings with the Color Trails Test, an executive 
functioning task, and SRT, a verbal test of memory, were similar. Most prior studies of 
cognitive dysfunction and metabolic control have examined only executive dysfunction as it 
relates to metabolic control. Diabetes mellitus self-management requires complex thought 
processing with mental flexibility, which is an attribute of executive functioning. Memory 
may also be important for diabetes mellitus self-management, specifically for tasks related 
to meal preparation, medication adherence, and administration of diabetes mellitus 
medications, and should be examined. Appropriate self-management of diabetes mellitus is 
important for the prevention of diabetes mellitus–related complications and adverse 
outcomes, such as micro- and macrovascular disease and death.1 Mild dysfunction in 
executive functioning and memory did not seem to affect self-management of diabetes 
mellitus in this sample of older adults.
Several limitations should be considered. First, the examination of cognition relied on a 
discrete number of tests, particularly for executive dysfunction, which is complex and 
difficult to measure.18 It is possible that a more-comprehensive battery would have found 
that cognition affects diabetes mellitus control, but the current authors found that ever 
having cognitive dysfunction was not associated with diabetes mellitus control. Second, the 
sampling frame for this study was participants in a randomized controlled trial (RCT), and 
the potential for selection bias in RCTs is high, with the healthiest and most educated 
individuals likely to enroll. It is possible that the results are not generalizable to clinic-based 
samples. It is also possible that the minority sample with a relatively low educational 
achievement was somewhat homogeneous from diabetes mellitus control and cognitive 
performance standpoints, explaining the null findings. Third, data were not available to 
estimate change in diabetes mellitus medication use to account for the possible confounding 
by indication, with individuals who control their diabetes mellitus with insulin being 
observed to have greater baseline executive dysfunction. Last, it is possible that the 
Medicare recipients with diabetes mellitus in the sample received assistance from formal 
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(e.g., nurses) or informal (e.g., relatives) caregivers, but related data were not collected, so 
this could not be taken into account. Participants with cognitive impairment could have 
overcome its effects on diabetes mellitus control through the assistance of formal or 
informal caregivers. Collection of these data was not part of the original design of the study, 
although mild cognitive dysfunction of any type was not associated with diabetes mellitus 
self-care activities or self-efficacy. If third-party assistance explained the null findings, one 
would expect to find a relationship between cognitive dysfunction and these self-care 
variables but not between cognitive dysfunction and direct measures of diabetes mellitus 
control. Nonetheless, it would be useful to collect data on third-party assistance in relation to 
cognitive dysfunction in diabetes mellitus. Significant strengths of the study include the 
large sample size and detailed longitudinal data on cognition and diabetes mellitus control 
parameters. More-severe cognitive dysfunction (e.g., dementia) could affect diabetes 
mellitus control, but this study addressed mild dysfunction, which is the most common in 
clinical practice.
Diabetes mellitus is a complex disease that requires a substantial amount of self-
management. Identifying what factors may inhibit ideal self-management is important so 
that it may be addressed in the clinical setting, where the provider can provided targeted 
education. Mild cognitive dysfunction was not related to diabetes mellitus control in this 
sample of elderly diabetics. Future studies need to explore whether assistance prompted by 
cognitive dysfunction, which could not be addressed, could explain these null findings.
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